Research and Clinical Trials

Minnesota sisters discover they have a shared genetic mutation that dramatically increases their risk for breast and ovarian cancer.

Associated with relapse-free survival, the genes may play a role in triggering inflammation to initiate an immune system response.

Researchers find that a gene may play a role in causing people with telomere biology disorders to have a high risk of developing blood cancer.

Mayo Clinic research has filled critical gaps in the understanding of how breast cancer genes predispose women to the disease.

Researchers built a highly accurate artificial intelligence model for fully automated cancer detection, including small and otherwise difficult-to-detect tumors.

Dr. Lida Mina says treatment for metastatic breast cancer has advanced, allowing people to live longer with a better quality of life.

Researchers have discovered new genetic markers to identify Lynch syndrome-associated colorectal cancer with high accuracy.

Researchers at Mayo Clinic are studying a vaccine-immunotherapy combination to stop ovarian cancer from progressing.

Dr. Judy Boughey explains why some people with multiple tumors may be able to receive a lumpectomy followed by whole-breast radiation therapy.

A condensed hypofractionated schedule of proton therapy resulted in excellent control of cancer while sparing surrounding tissue.